Lifeloc Technologies secures $750,000 subordinated debenture with 8.25% interest and warrants

Lifeloc Technologies, Inc

Issued $750,000 subordinated debenture to Diamond Bridge Capital at 8.25% interest, maturing Dec 31, 2030; quarterly interest through 2025 then monthly P&I.
Warrant to purchase 62,500 shares at $4.50 per share, exercisable until Dec 31, 2031; includes registration rights.
Proceeds to support growth, fund R&D and commercialization of SpinDx drug detection technology.
Projections show path to profitability by 2027 with sales growing from $8.5M (2024E) to $19.5M (2028E).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.